<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Y</submitter><funding>Fundamental Research Funds for the Central Universities</funding><funding>Research Project of Jinan Microecological Biomedicine Shandong Laboratory</funding><funding>Shandong Provincial Laboratory Project</funding><funding>CAMS Innovation Fund for Medical Sciences</funding><funding>Zhejiang Provincial Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><pagination>506</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11606014</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Klebsiella pneumoniae has emerged as a significant pathogen that causes community and hospital infections due to its high resistance rate and transmissibility. Klebsiella pneumoniae complex is classified into three phylogroups: Klebsiella pneumoniae (KpI), Klebsiella quasipneumoniae (KpII), and Klebsiella variicola (KpIII) in classical taxonomy, but KpII and KpIII are infrequently isolated clinically. Although pathogenic KpII has been reported worldwide, the understanding of this pathogen remains limited.&lt;h4>Methods&lt;/h4>Whole-genome sequencing (WGS) of K. quasipneumoniae subsp. similipneumoniae ACESH00366hy was performed. Plasmid characterization was demonstrated using S1-PFGE, Southern blotting, and conjugation assays. Antimicrobial susceptibility testing was performed </pubmed_abstract><journal>BMC microbiology</journal><pubmed_title>Genomic and phenotypic characterization of ST2012 clinical Klebsiella quasipneumoniae subsp. similipneumoniae harboring bla&lt;sub>NDM-1&lt;/sub> in China.</pubmed_title><pmcid>PMC11606014</pmcid><funding_grant_id>LHDMZ22H190002</funding_grant_id><funding_grant_id>2020YFE0204300</funding_grant_id><funding_grant_id>SYS202202</funding_grant_id><funding_grant_id>82072314</funding_grant_id><funding_grant_id>JNL-2022011B</funding_grant_id><funding_grant_id>2019-I2M-5-045</funding_grant_id><funding_grant_id>2022ZFJH003</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Qian J</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Zheng B</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Xu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genomic and phenotypic characterization of ST2012 clinical Klebsiella quasipneumoniae subsp. similipneumoniae harboring bla&lt;sub>NDM-1&lt;/sub> in China.</name><description>&lt;h4>Background&lt;/h4>Klebsiella pneumoniae has emerged as a significant pathogen that causes community and hospital infections due to its high resistance rate and transmissibility. Klebsiella pneumoniae complex is classified into three phylogroups: Klebsiella pneumoniae (KpI), Klebsiella quasipneumoniae (KpII), and Klebsiella variicola (KpIII) in classical taxonomy, but KpII and KpIII are infrequently isolated clinically. Although pathogenic KpII has been reported worldwide, the understanding of this pathogen remains limited.&lt;h4>Methods&lt;/h4>Whole-genome sequencing (WGS) of K. quasipneumoniae subsp. similipneumoniae ACESH00366hy was performed. Plasmid characterization was demonstrated using S1-PFGE, Southern blotting, and conjugation assays. Antimicrobial susceptibility testing was performed </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-03T01:03:15.005Z</modification><creation>2025-04-04T01:58:12.726Z</creation></dates><accession>S-EPMC11606014</accession><cross_references><pubmed>39614148</pubmed><doi>10.1186/s12866-024-03637-2</doi></cross_references></HashMap>